Search

everythinglearnresearchcommunity

for

Search:↓

New cancer drugs can cause skin side effects like rashes, dry skin, hair changes, and nail problems.

Targeting NMMHC IIA may help treat blood-brain barrier damage.

Saw Palmetto can cause severe liver damage.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

Social media can help compare the effectiveness and safety of new arthritis medications.

Switching JAK inhibitors can lead to significant hair regrowth in severe alopecia cases.

Berberine delivery systems improve wound healing by enhancing bioavailability, reducing inflammation, and promoting tissue regeneration.

Cuscuta reflexa leaves extract may help lower blood sugar and improve diabetes symptoms.

Endoplasmic reticulum stress plays a key role in developing atherosclerosis.

Warfarin is effective but risky, requiring careful monitoring to prevent bleeding.

New compounds may help treat heart disease by activating specific potassium channels.

Selaginella doederleinii extract shows potential for cervical cancer treatment but needs more research.

Nirmatrelvir/Ritonavir treatment may lead to a weaker immune response to COVID-19, but doesn't affect the chance of rebound.

CTP-543 is generally safe for treating alopecia areata.

Dihydroartemisinin helps reduce prostate enlargement in rats by stopping the growth of prostate cells.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

Bortezomib chemotherapy can cause temporary skin rashes.

Changing the 6-position on benzopyran molecules affects insulin release, with some compounds showing strong inhibitory effects.

Rats had lasting erectile problems after stopping a certain medication.

Baricitinib is the most effective treatment for alopecia areata.

Abrus precatorius has medicinal benefits but can be toxic.

Different medications can cause serious side effects in some people.

JAK inhibitors can help regrow hair in alopecia areata but have potential long-term risks and require careful monitoring.

The document confirms the structures of major metabolites of the CRTh2 antagonist Setipiprant and identifies minor metabolites.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

Vemurafenib can cause scalp issues but can be managed without changing the dose.